Document Detail

Regression of left ventricular hypertrophy by converting enzyme inhibition in 12-15-month-old spontaneously hypertensive rats: effects on coronary resistance and ventricular compliance in normoxia and anoxia.
MedLine Citation:
PMID:  7511729     Owner:  NLM     Status:  MEDLINE    
The effects of trandolapril, a converting enzyme inhibitor (CEI), on left ventricular (LV) diastolic stiffness and coronary vascular resistance (CVR), were studied with an isolated heart preparation in 15-month-old spontaneously hypertensive rats (SHR). The hypertensive animals were treated for 3 months with trandolapril (0.3 mg/kg/day) (SHRT), and compared with untreated age-matched Wistar-Kyoto rats (WKY) and SHR. Trandolapril treatment resulted in 15% diminution in blood pressure (BP). In contrast, it completely normalized left ventricular (LV) weight. Untreated SHR, as compared with WKY, had a dilated LV and increased diastolic tissue stiffness. Trandolapril had no effect on either chamber or tissue stiffness. Five-minute anoxia resulted in the same dramatic increase in chamber stiffness in every experimental group. During anoxia, as during normoxia, tissue stiffness was still greater in SHR than in WKY. A major effect of CEI was to normalize the tissue stiffness of SHR under anoxia. Coronary vascular resistance (CVR) was increased in SHR as compared with WKY. Trandolapril improves CVR and significantly shifts the coronary pressure flow curve to the dilatory side. Both collagen concentration (approximately 2 mg/g) and the content in slow V3 myosin isoform, used as biologic markers of cardiac senescence, were the same in the three experimental groups, but higher than in young hearts. Trandolapril had no effect on these parameters. In semisenescent SHR, despite having rather slight effect on arterial pressure, trandolapril completely normalized LV weight. In addition, collagen content and its physiologic counterpart, tissue stiffness, were unaffected by 3-month treatment with trandolapril. Nevertheless, the anoxia-induced increase in LV tissue stiffness was improved by trandolapril in parallel with reduction in LV hypertrophy (LVH).
F C Amrani; S L Cheaw; B Chevalier; F Paolaggi; S Jouquey; G Hamon; B Swynghedauw
Related Documents :
12444299 - Mechanism of the antihypertensive effect of stevioside in anesthetized dogs.
8948009 - Enduring effects of infant feeding experiences on adult blood pressure.
10327389 - Effect of ouabain in pressurized middle cerebral arteries from normotensive and hyperte...
11061349 - Myocardial function during chronic food restriction in isolated hypertrophied cardiac m...
21279799 - Southern negro migration: social and economic components of an ecological model.
1735579 - Rapid eye movement sleep deprivation and hypertension. genetic influence.
11016799 - The influence of the peripheral reflection wave on left ventricular hypertrophy in pati...
24292299 - Blood pressure in different levels of bmi.
988549 - Norepinephrine and isoprenaline induced changes of peripheral blood flow acceleration c...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  23     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1994 Jan 
Date Detail:
Created Date:  1994-05-02     Completed Date:  1994-05-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  155-65     Citation Subset:  IM    
U127-INSERM, Hopital Lariboisière, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin-Converting Enzyme Inhibitors / pharmacology,  therapeutic use*
Anoxia / physiopathology
Blood Pressure / drug effects
Coronary Vessels / drug effects*
Disease Models, Animal
Heart Ventricles / drug effects
Hypertension / drug therapy*
Hypertrophy, Left Ventricular / drug therapy*
Indoles / pharmacology,  therapeutic use*
Rats, Inbred SHR
Rats, Inbred WKY
Vascular Resistance / drug effects*
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Indoles; 87679-37-6/trandolapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Converting enzyme inhibition improves congestion and survival in hypertensive rats with high-output ...
Next Document:  Effect of clentiazem (TA-3090) with posttreatment on neurologic and histologic disorders of stroke-p...